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the behavioral consequences of lack
of CD38, it seems likely that CD38-
mediated mechanisms are also in-
volved in the release of oxytocin (and
possibly other neuropeptides) within
the brain. The results make a search
for human CD38 mutations tempting,
for example in patients with severe
disturbances in social behaviors, in-
cluding social phobia and autism.
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Metabolism and mitochondrial activity are thought to be important determinants of life span. A new
study in this issue of Cell Metabolism (Bonawitz et al., 2007) suggests that the TOR pathway controls
mitochondrial respiration in yeast and that the harder mitochondria work, the longer yeast live.In 1928, the noted but controversial
biologist Raymond Pearl published
a treatise entitled The Rate of Living,
Being an Account of Some Experimen-
tal Studies on the Biology of Life Dura-
tion, in which he argued that metabolic
rate was the key determinant of an
organism’s life span. The immediate
impact and acceptance of Pearl’s
idea was muted, perhaps due to the
author’s own flamboyant past, which
included advocating the consumption
of significant quantities of alcohol as
a way to prolong life. Nonetheless, in
contrast to his other ignoble theories,
Pearl’s work on metabolism was not
completely dismissed. Indeed, 30
years later, it would coalesce with the
work of Denham Harman and his
‘‘free-radical theory of aging’’ to form
a single notion, that aging represents
the end result of metabolically induced
oxidant-mediated damage.The Pearl-Harman notion was that
faster metabolism (increased oxygen
consumption) leads to increased reac-
tive oxygen species (ROS) formation
and hence shorter life span. Surpris-
ingly, three-quarters of a century after
Pearl’s initial treatise, the molecular
basis for differences in metabolic rate
within and between organisms, as
well as the relationship between oxy-
gen consumption and ROS formation,
remains largely unknown. Now, a pa-
per in this month’s issue ofCell Metab-
olism begins to peel away the mystery
surrounding some of these decades-
old questions (Bonawitz et al., 2007).
The current work centers on the
TOR pathway in yeast and its role in
aging. Yeast aging is usually analyzed
in one of two different assays. Replica-
tive life span is defined as the number
of times a mother yeast cell can give
rise to a daughter bud, while chrono-Cell Metabolislogical life span is the length of time
that a nondividing yeast cell can re-
main viable in culture. In mammals,
this distinction may be analogous to
assessing aging in dividing versus
postmitotic cells. S. cerevisiae has
two TOR genes that are partially but
not completely redundant. Yeast de-
leted in the TOR2 gene are not viable,
while deletion of TOR1 increases
replicative life span (Kaeberlein et al.,
2005). In general, TOR represents
a central signaling node that coordi-
nates cell growth with the underlying
cellular energy state. In the presence
of nutrients, when the energy stores
of a yeast cell are high, TOR coordi-
nates increases in translation, tran-
scription, and ribosomal biogenesis
while inhibiting the self-consuming
process of autophagy. Interestingly,
diminished TOR signaling can also ex-
tend the life span of other organismsm 5, April 2007 ª2007 Elsevier Inc. 233
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Previewssuch as flies and worms (Kapahi
et al., 2004; Vellai et al., 2003). In
mammals, although much of the
mechanics of TOR signaling is
largely conserved, it is presently
unknown whether diminished
mTOR activity correlates with an
extension of life span.
The new study (Bonawitz et al.,
2007) extends these past observa-
tions by demonstrating that dele-
tion of TOR1 also leads to exten-
sion of chronological life span.
Surprisingly, and in direct contrast
to what Raymond Pearl would
have predicted, long-lived yeast
deficient in TOR1 have greater
rather than reduced oxygen con-
sumption. In the present study,
however, these differences in lon-
gevity and oxygen consumption
were completely dependent on
the presence of extracellular glu-
cose. In wild-type yeast, the pres-
ence of glucose triggers a number
of metabolic changes, but for our
discussion, the most important is
a shift whereby ATP is generated
less from mitochondrial activity
and more from anaerobic fermen-
tation (see Figure 1). A similar
glucose-dependent shift in respi-
ration does not occur in mammals.
Nonetheless, in wild-type yeast
strains, shifting from glycerol to glu-
cose as a carbon source triggers a de-
crease in mitochondrial respiration.
The new study demonstrates that this
mitochondrial shutoff does not happen
to the same degree in TOR1-deleted
yeast. Indeed, direct assessment of
translation of mitochondria-encoded
subunits revealed that the TOR1-de-
leted strain continuously synthesizes
high levels of mitochondrial compo-
nents compared to the wild-type
strain. Together, these results suggest
that, in yeast, TOR signaling might
directly regulate mitochondrial bio-
genesis.
Bonawitz et al. (2007) provide a num-
ber of experiments suggesting that, in
the TOR1-deleted strain, the relation-
ship between increased mitochondrial
activity and increased chronolog-
ical life span may be causative and
not merely correlative. For instance,
deletion of TOR1 does not lead to
life-span increases in yeast strains
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Similarly, the authors demonstrate
that other strains that are unable to
undergo the glucose-induced shutoff
of respiration are also long lived. This
leads the authors to conclude that di-
minished TOR1 signaling extends life
span by directly or indirectly regulating
mitochondrial activity. This stands in
contrast to other investigators who
have argued that reducing TOR signal-
ing increases longevity by mediating
an increase in stress resistance
(Powers et al., 2006). Interestingly, in
mammalian cells, factors that stim-
ulate increased mitochondrial num-
bers also appear to simultaneously
orchestrate an increase in oxidant
scavenging (St-Pierre et al., 2006),
suggesting that, in some cases, in-
creased stress resistance and aug-
mented mitochondrial activity may be
tightly coupled.
How does an increase in mitochon-
drial respiration lead to an increase in
chronological life span? The mecha-
gure 1. TOR Activity Negatively Regulates
fe Span
eletion of TOR1 in yeast leads to life-span extensio
the manuscript by Bonawitz and colleagues (2007
is effect is only seen in the presence of glucos
nder these conditions, TOR1 sends a signal that in
bits mitochondrial activity, leading to a shift awa
m aerobic respiration and toward increased fermen
tion. This metabolic alteration is thought to lead
creased reactive oxygen species formation and
crease in life span. In the absence of TOR1, th
ucose-dependent decrease in respiration does n
cur, and the continuation of high levels of mitochon
ial activity promotes increased chronological li
an. While TOR1 appears to regulate mitochondri
tivity, the mitochondria can also influence TOR a
ity through a process known as retrograde signalinElsevier Inc.nism proposed by Bonawitz et al.
(2007) is a decrease in ROS
formation. This supposition seems
counterintuitive at first glance
since ROS formation is a byprod-
uct of respiration. Nonetheless,
the formation of superoxide in the
mitochondria requires two com-
ponents to collide, molecular oxy-
gen and a free electron. Busymito-
chondria rapidly pass electrons
down the electron transport chain
and avidly consume oxygen, in
doing so depleting the two com-
ponents necessary for ROS forma-
tion. In this manner, it is proposed
that an increase in respiration
could lead to less—not more—
ROS generation. This is also con-
sistent with other data in yeast
concerning the role of Sir2 and ca-
loric restriction, where, again,
there is evidence that the ob-
served increase in replicative life
span is mediated by increased
mitochondrial activity (Lin et al.,
2002).
It remains unclear how much of
what has been learned in lower or-
ganisms will be directly transfer-
able to mammals. For instance,
we recently observed that in con-
trast to what is seen in the current
tudy, in mammalian cells, mTOR ac-
vity positively correlates with mito-
hondrial activity (Schieke et al.,
006). A similar positive correlation in
ammals between mTOR and mito-
hondrial biogenesis has also been
bserved by others (P. Puigserver, un-
ublished data). As Bonawitz et al.
007) point out, this difference may
e related to yeast’s unusual propen-
ity to favor anaerobic fermentation in
e setting of extracellular glucose,
feat that mammalian cells, despite
ll of their sophistication, cannot dupli-
ate. Nonetheless, all of these obser-
ations enlarge the sphere of influence
f the TOR pathway to now includemi-
chondrial regulation. Previous stud-
s have clearly shown that altering mi-
chondrial activity can, in what is
nown as retrograde signaling, feed
ack and regulate TOR activity (Liu
nd Butow, 2006). These new results
uggest that a feed-forward pathway
xists as well, wherein TOR activity
gulates mitochondrial activity.
Cell Metabolism
PreviewsMany years after Raymond Pearl’s
‘‘rate of living’’ theory was proposed,
many fundamental questions remain
unresolved. First among these is the
simple question of whether more mito-
chondrial activity makes one live lon-
ger or not. Progress in this area has
perhaps been stifled by the belief that
aerobic metabolism is regulated solely
by the availability of nutrients and re-
ducing equivalents. Such notions are
slowly giving way to a more nuanced
view in which cellular signaling path-
ways intersect with the mitochondria,
creating a two-way network of interac-
tions between the consumer (the
cell) and the supplier (the mitochon-
dria) of energy. Undoubtedly, the
answer to Pearl’s 75-year-old questionlies somewhere in this web of
interactions.
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